LABORATORIO REIG JOFRE (ES:RJF) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Laboratorio Reig Jofre, S.A. continues its international expansion with the establishment of a new subsidiary, RJ CZECH REPUBLIC, in the Czech Republic, focusing on osteoarticular and dermatology products. This move, following the opening of a subsidiary in Poland in 2021, is part of the company’s growth strategy to strengthen its presence in Eastern Europe and its international sales network. The new subsidiary will contribute to the company’s growth, with Reig Jofre reporting 2023 sales of 316 million euros and an EBITDA of 35 million euros.
For further insights into ES:RJF stock, check out TipRanks’ Stock Analysis page.